Compare PRTA & GTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRTA | GTN |
|---|---|---|
| Founded | 2012 | 1897 |
| Country | Ireland | United States |
| Employees | N/A | 9582 |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 539.9M | 446.1M |
| IPO Year | 2013 | N/A |
| Metric | PRTA | GTN |
|---|---|---|
| Price | $10.49 | $5.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $19.00 | $8.50 |
| AVG Volume (30 Days) | 449.6K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 5.62% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $814,000.00 | N/A |
| Revenue This Year | $1,111.38 | $13.89 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.32 | $3.13 |
| 52 Week High | $11.69 | $6.31 |
| Indicator | PRTA | GTN |
|---|---|---|
| Relative Strength Index (RSI) | 60.65 | 70.84 |
| Support Level | $9.69 | $5.50 |
| Resistance Level | $10.90 | $6.04 |
| Average True Range (ATR) | 0.39 | 0.25 |
| MACD | 0.08 | 0.13 |
| Stochastic Oscillator | 79.77 | 95.12 |
Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.
Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios. The company's segments include Broadcasting and Production Companies. The majority of revenue is derived from broadcast and digital advertising and from retransmission consent fees.